Controlled attenuation parameter for evaluating liver steatosis in type 2 diabetes patients

被引：0

作者：

Sporea, Ioan ^{[1
]}

Mare, Ruxandra ^{[1
]}

Lupusoru, Raluca ^{[1
]}

Silviu, Nistorescu ^{[1
]}

Popescu, Alina ^{[1
]}

Sirli, Roxana ^{[1
]}

Danila, Mirela ^{[1
]}

机构：

[1] Victor Babes Univ Med & Pharm, Gastroenterol & Hepatol, Timisoara, Romania

来源：

JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT-328

引用

页码：E784 / E784

页数：1

共 50 条

[31] Controlled attenuation parameter reflects steatosis in compensated advanced chronic liver disease [J].

Piccinni, Rosangela ;

Rodrigues, Susana G. ;

Montani, Matteo ;

Murgia, Giuseppe ;

Delgado, Maria G. ;

Casu, Stefania ;

Stirnimann, Guido ;

Semmo, Nasser ;

De Gottardi, Andrea ;

Dufour, Jean-Francois ;

Berzigotti, Annalisa .

LIVER INTERNATIONAL, 2020, 40 (05) :1151-1158

[32] Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens) [J].

Ferraioli, Giovanna .

JOURNAL OF MEDICAL ULTRASONICS, 2021, 48 (04) :489-495

[33] Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter [J].

Ferraioli, Giovanna ;

Calcaterra, Valeria ;

Lissandrin, Raffaella ;

Guazzotti, Marinella ;

Maiocchi, Laura ;

Tinelli, Carmine ;

De Silvestri, Annalisa ;

Regalbuto, Corrado ;

Pelizzo, Gloria ;

Larizza, Daniela ;

Filice, Carlo .

BMC GASTROENTEROLOGY, 2017, 17

[34] Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter [J].

Giovanna Ferraioli ;

Valeria Calcaterra ;

Raffaella Lissandrin ;

Marinella Guazzotti ;

Laura Maiocchi ;

Carmine Tinelli ;

Annalisa De Silvestri ;

Corrado Regalbuto ;

Gloria Pelizzo ;

Daniela Larizza ;

Carlo Filice .

BMC Gastroenterology, 17

[35] Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity [J].

Yang, Lin ;

Lin, Yan ;

Zhu, Ya Fei ;

Zhu, Yin Yan ;

Liang, Zhen Ming ;

Wu, Guang Sheng .

PEDIATRIC OBESITY, 2022, 17 (06)

[36] Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter [J].

Yen, Y. H. ;

Kuo, F. Y. ;

Lin, C. C. ;

Chen, C. L. ;

Chang, K. C. ;

Tsai, M. C. ;

Hu, T. H. .

TRANSPLANTATION PROCEEDINGS, 2018, 50 (10) :3533-3538

[37] Quantitative assessment of liver steatosis using ultrasound controlled attenuation parameter (Echosens) [J].

Giovanna Ferraioli .

Journal of Medical Ultrasonics, 2021, 48 :489-495

[38] Validating controlled attenuation parameter in the assessment of hepatic steatosis in living liver donors [J].

Broering, Dieter ;

Shawkat, Mohamed ;

Albenmousa, Ali ;

Abaalkhail, Faisal ;

Alabbad, Saleh ;

Al-Hamoudi, Waleed ;

Alghamdi, Saad ;

Alqahthani, Saleh ;

Jaafari, Ahmad ;

Troisi, Roberto ;

Bzeizi, Khalid .

PLOS ONE, 2021, 16 (05)

[39] The Role of Controlled Attenuation Parameter (CAP) in Defining Significant Hepatic Steatosis in Chronic Liver Disease Patients [J].

Andrade, Patricia ;

Rodrigues-Pinto, Eduardo ;

Gaspar, Rui ;

Lopes, Joanne ;

Lopes, Susana ;

Macedo, Guilherme .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 :S880-S880

[40] Ultrasound and FibroScan® Controlled Attenuation Parameter in patients with MAFLD: head to head comparison in assessing liver steatosis [J].

Salmi, Andrea ;

di Filippo, Luigi ;

Ferrari, Clarissa ;

Frara, Stefano ;

Giustina, Andrea .

ENDOCRINE, 2022, 78 (02) :262-269

← 1 2 3 4 5 →